Commencing January 2027, the Trish MS Research Foundation will be funding a $400,000 Translational MS Research Project Grant which will be awarded to an Australian researcher undertaking high-quality translational MS research which demonstrates clear evidence of translational research capacity.
Applications will open on 16 March 2026 and close on 24 April 2026, and should be submitted via MS Australia’s Project Grants application process through MS Australia’s online grant portal, https://grants.msaustralia.org.au.
As part of the Project Grants application, applicants will be able to tick a checkbox indicating that they wish to be considered for the Trish Translational MS Research Project Grant, and will be directed to answer a small number of additional questions.
Applications must fulfil the following criteria:
- Applications must be aligned with the funding principles of the Trish MS Research Foundation.
- Applications will need to include at least one collaborator with a strong track record in MS research and/or the clinical management of MS, and the collaborative team will need to demonstrate the required multi-disciplinary expertise to complete all elements of the study.
- Applications involving commercial partners, where relevant, are encouraged.
- Applications involving investigators from other disease fields are encouraged.
- Your Translational Research Project Grant must demonstrate direct relevance for the prevention and/or reversal of disability in MS and be aimed to address the unmet needs of people living with Progressive MS. Applications solely addressing the control/suppression of inflammatory relapses in MS will not be considered.
- Applications must demonstrate a clear, feasible pathway for clinical implementation.
Before applying for the Translational MS Research Project Grant please read the Funding Process Description, Conditions of Award, Eligibility Criteria and Peer Review Commentary Template below.